What smart money is saying about GenScript Biotech
1548.HK
No fund has written a full thesis on GenScript Biotech in our archive, but 2 fund letters report a position in it — most recently Liontrust China Fund in September 2026.
Get an email when a fund buys, sells or pitches it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Every position in GenScript Biotech on record in the archive was reported in Q3 2026, across 2 fund letters, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 0 | 0 |
Fund activity · 2 positions
- HoldsLiontrust China FundSeptember 2026
“● Health care was by far the strongest contributor to relative performance, benefiting from strength across holdings including WuXi Biologics, WuXi AppTec and GenScript Biotech.”
GenScript Biotech - HoldsMatthews China FundSeptember 2026
“Health Care was a leading source of relative performance, supported by GenScript Biotech and WuXi AppTec.”
GenScript Biotech
Read the letters behind these GenScript Biotech positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger